A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With ISN/RPS 2003 Class III or IV Lupus Nephritis
Clinical trial NCT04221477 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04221477
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-10
- Primary completion
- 2024-08-15
- Enrollment
- 271
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.